Structure Therapeutics (GPCR) Other Non-Current Assets (2022 - 2026)
Structure Therapeutics (GPCR) recorded quarterly Other Non-Current Assets of $5.6 million in Q1 2026, up 674.76% quarter-over-quarter from $717000.0 in Q4 2025, and down 8.87% on a YoY basis from $6.1 million in Q1 2025.
Structure Therapeutics (GPCR) Other Non-Current Assets (2022 - 2026) Analysis & Trends
Structure Therapeutics' Other Non-Current Assets history runs 5 years deep, the most recent figure standing at $5.6 million for Q1 2026.
- In Q1 2026, Other Non-Current Assets fell 8.87% year-over-year to $5.6 million; the TTM figure through Mar 2026 stood at $5.6 million (down 8.87% YoY), while the FY2025 annual figure was $717000.0, down 85.96% from the prior year.
- Other Non-Current Assets was $5.6 million for Q1 2026 at Structure Therapeutics, up from $717000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $6.6 million in Q3 2025 to a low of $38000.0 in Q2 2023.
- Historically, Other Non-Current Assets has averaged $2.7 million across 5 years, with a median of $1.8 million in 2024.
- The sharpest annual moves came in 2023 and 2025: Other Non-Current Assets plunged 98.7% in 2023, then soared 12870.21% in 2025.
- A 5-year view of Other Non-Current Assets shows it stood at $3.5 million in 2022, then slumped by 98.7% to $45000.0 in 2023, then jumped by 11246.67% to $5.1 million in 2024, then sank by 85.96% to $717000.0 in 2025, then soared by 674.76% to $5.6 million in 2026.
- The last three Other Non-Current Assets figures came in at $5.6 million (Q1 2026), $717000.0 (Q4 2025), and $6.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 60,000.00 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Structure Therapeutics | 9.35 Bn | 9.35 Bn | - | 5.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.56 Mn |
| Dec 31, 2025 | 717,000.00 |
| Sep 30, 2025 | 6.60 Mn |
| Jun 30, 2025 | 6.20 Mn |
| Mar 31, 2025 | 6.10 Mn |
| Dec 31, 2024 | 5.11 Mn |
| Sep 30, 2024 | 1.82 Mn |
| Jun 30, 2024 | 1.83 Mn |
| Mar 31, 2024 | 47,000.00 |
| Dec 31, 2023 | 45,000.00 |
| Sep 30, 2023 | 350,000.00 |
| Jun 30, 2023 | 38,000.00 |
| Mar 31, 2023 | 59,000.00 |
| Dec 31, 2022 | 3.46 Mn |